Quality of life 1 year after uterine artery embolization vs hysterectomy for symptomatic adenomyosis ( QUESTA study)
Acta Obstetricia et Gynecologica Scandinavica · 2025-08 · 104 (8) · 1558-1574
DOI: 10.1111/aogs.15165 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Acta Obstetricia et Gynecologica Scandinavica, online erschienen am 26.05.2025. Verfasst von Lisa M Trommelen und 40 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Amsterdam UMC, Location VUMC and AMC, Amsterdam, The Netherlands. Hauptthemen laut MEDLINE: Adenomyosis, Quality of Life, Hysterectomy, Uterine Artery Embolization. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Boston Scientific Corporation, Merit Medical Systems.
Abstract (Originalsprache)
Introduction
Uterine artery embolization (UAE) is a less‐invasive alternative for hysterectomy in therapy‐resistant symptomatic adenomyosis. Comparative data are lacking. Our objective is to evaluate the non‐inferiority of UAE compared with hysterectomy in improving health‐related quality of life (HRQOL) for symptomatic adenomyosis, 1 year post‐treatment. Material and Methods This multicenter randomized controlled trial was converted into a prospective cohort study. It was prospectively registered at 27‐07‐2015 (NL‐OMON55436, https://onderzoekmetmensen.nl/en/trial/55436 ). From November 2015 to March 2022 participants with symptomatic adenomyosis eligible for hysterectomy were included and offered UAE as an alternative treatment. Primary endpoint was difference in 1‐year HRQOL scores between UAE and hysterectomy, using WHO‐QOL‐Bref and SF‐12. Non‐inferiority margin was set at five points. Secondary endpoints: WHO‐QOL‐100 facets “Pain and Discomfort” and “Sexual Activity”, adenomyosis‐related symptoms, and satisfaction. Multivariable linear mixed models were used. All outcomes were analyzed in the per‐protocol population, and repeated in the intention‐to‐treat population.
Results
Of 101 participants, 51 chose hysterectomy and 50 UAE. Both treatment groups were comparable at baseline, except for employment status, dysmenorrhea score, uterine volume, hemoglobin and CA125 (all adjusted for). Both treatments led to a significant increase in all HRQOL scores after 1 year. The effect differences between UAE and hysterectomy on all HRQOL domains in the per‐protocol population were: SF‐12 physical β −4.20, (95% CI −9.53 to 1.12), SF‐12 mental β −4.95 (95% CI −10.83 to 0.94); WHO‐QOL‐Bref physical β −7.42 (95% CI −18.51 to 3.68), psychological β −4.28 (95% CI −13.30 to 4.74), social relations β −2.23 (95% CI −13.09 to 8.63) and environment β 0.35 (95% CI −8.39 to 9.09). Non‐inferiority of UAE was not demonstrated within the predefined margin. Both hysterectomy and UAE improved “Pain and Discomfort” and “Sexual Activity”, with greater effect on pain after hysterectomy ( β 17.17, 95% CI 4.94 to 29.41, p = 0.007). More participants were satisfied after hysterectomy (95%) than after UAE (73%).
Conclusions
Both UAE and hysterectomy significantly increased HRQOL for symptomatic adenomyosis. Neither non‐inferiority nor inferiority of UAE could be established. One‐year HRQOL scores were comparable; some secondary outcomes were in favor of hysterectomy. UAE is a valid less‐invasive alternative to hysterectomy, with preservation of the uterus. Hysterectomy remains the treatment of choice for patients seeking a definite solution.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, Amsterdam UMC, Location VUMC and AMC, Amsterdam, The Netherlands.
- Amsterdam Reproduction and Development (AR&D), Research Institute, Amsterdam, The Netherlands.
- Department of Obstetrics and Gynecology, Elisabeth Tweesteden Ziekenhuis, Tilburg, The Netherlands.
- Department of Obstetrics and Gynecology, Amphia Ziekenhuis, Breda, The Netherlands.
- Department of Obstetrics and Gynecology, Maxima Medical Center, Eindhoven, The Netherlands.
- Department of Obstetrics and Gynecology, OLVG, Amsterdam, The Netherlands.
ORCID-Profile: Lisa M Trommelen
Förderung
- Boston Scientific Corporation
- Merit Medical Systems
Zitieren
APA
Trommelen, L. M., Semmler, A., de Bruijn, A. M., Harmsen, M., Smink, M., Janssen, P. F., van Rooij, I., van Bavel, J., Geomini, P., Maas, J. W. M., Radder, C. M., van Kesteren, P., Kwee, J., Bakkum, E., de Lange, M., de Leeuw, R. A., Groenman, F., Mijatovic, V., Timmermans, A., …, & Hehenkamp, W. J. K. (2025). Quality of life 1 year after uterine artery embolization vs hysterectomy for symptomatic adenomyosis ( QUESTA study). Acta Obstetricia et Gynecologica Scandinavica, 104(8), 1558-1574. https://doi.org/10.1111/aogs.15165
Vancouver
Trommelen LM, Semmler A, de Bruijn AM, Harmsen M, Smink M, Janssen PF, et al. Quality of life 1 year after uterine artery embolization vs hysterectomy for symptomatic adenomyosis ( QUESTA study). Acta Obstetricia et Gynecologica Scandinavica. 2025;104(8):1558-1574. doi:10.1111/aogs.15165
BibTeX
@article{Trommelen2025,
author = {Trommelen, Lisa M and Semmler, Annika and de Bruijn, Annefleur M and Harmsen, Marissa and Smink, Marieke and Janssen, Petra F and van Rooij, Ilse and van Bavel, Jeroen and Geomini, Peggy and Maas, Jacques W M and Radder, Celine M and van Kesteren, Paul and Kwee, Janet and Bakkum, Erica and de Lange, Marleen and de Leeuw, Robert A and Groenman, Freek and Mijatovic, Velja and Timmermans, Anne and Lely, Rutger and Lamers, Armand and Vos, Douwe and van Hoecke, Gretel and Elgersma, Otto and van Vliet, Huib A A M and Yo, Lonneke S F and Twijnstra, Andries R H and Jansen, Frank W and van Rijswijk, Catharina S P and Kruimer, Han and Tseng, Carroll M E S N and Coppus, Sjors and Arntz, Mark and Wust, Aloys F J and Blomjous, Joost G A M and van Boven, Laurens and Venmans, Alexander and Twisk, Jos W R and Huirne, Judith A F and Lohle, Paul N M and Hehenkamp, Wouter J K},
title = {Quality of life 1 year after uterine artery embolization vs hysterectomy for symptomatic adenomyosis ( QUESTA study)},
journal = {Acta Obstetricia et Gynecologica Scandinavica},
year = {2025},
volume = {104},
number = {8},
pages = {1558--1574},
doi = {10.1111/aogs.15165}
}
EUVIMED